Kirstine Frantz (Jacobsen)

Kirstine Frantz (Jacobsen) has extensive work experience in various roles and industries. Kirstine is currently working as a Senior Project Manager for CMC Biologics at ProtaGene since November 2022. Prior to that, Kirstine worked at Novo Nordisk for several years, starting in June 2016. At Novo Nordisk, they held positions as a Research Scientist in Injectable Formulation Development from January 2020 to November 2022, Research Scientist in Drug Product Analysis and Development from March 2018 to January 2020, and Quality Assurance in Insulin Manufacturing from June 2016 to March 2018.

Before joining Novo Nordisk, Kirstine was a Guest Researcher at the University of Southern Denmark from June 2016 to May 2021. Kirstine continued their collaboration with Professor Henrik Ditzel and other collaborators from the University of Bergen, Norway, and Instituto Oncologica Dr. Rosell, Spain, focusing on resistance to EGFR inhibitors in Non-small cell lung cancer.

Their earlier experience includes roles at the University of Southern Denmark, where they worked as a Research Assistant with responsibility for a biosafety level II laboratory from March 2011 to November 2011. Kirstine also served as a Teaching Assistant/Instructor from March 2007 to June 2011 and as an Ambassadeur of SDU from September 2007 to February 2009.

Throughout their career, Kirstine has gained valuable expertise in project management, biologics, formulation development, drug product analysis, quality assurance, and research in lung cancer resistance.

Kirstine Frantz (Jacobsen) has an extensive education history. Kirstine began their academic journey in 2005 at the University of Southern Denmark, where they pursued a Bachelor of Science (B.Sc.) in Biomedicine, graduating in 2008. Kirstine then continued their studies at the same university and obtained a Master of Science (M.Sc.) in Molecular Biosciences from 2008 to 2011.

In their pursuit of further knowledge and specialization, Kirstine Frantz undertook several visiting Ph.D. positions. Firstly, they spent five months, from 2013 to 2014, as a visiting Ph.D. student at the Women's Health Integrated Research Center. Kirstine then embarked on another visiting Ph.D. opportunity, this time at the University of Chinese Academy of Sciences, where they stayed for three months each in 2014 and 2015.

In 2015, Kirstine Frantz became a visiting Ph.D. student at the University of Bergen (UiB) for a duration of one month. Their research focus during this period is not specified.

The most significant milestone in their education history came from 2012 to 2016 when Kirstine Frantz pursued a Ph.D. in oncology and large-scale protein analysis at the University of Southern Denmark. Their doctoral studies provided their with a comprehensive understanding of these specialized areas.

Continuing their professional development, in 2019, Kirstine Frantz attended a Project Management course at the Copenhagen Business Academy, earning 10 ECTS credits.